Back to search
Endoscopic Sleeve Gastroplasty
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Endoscopic Sleeve Gastroplasty trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Endoscopic Sleeve Gastroplasty trials you may qualify forThe objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or…
This study is designed to compare weight loss outcomes and safety of ESG versus lifestyle modification in patients with obesity who discontinued GLP-1 therapy d…
Gastric myotomy has been performed for several years as a means of addressing chronic stenosis after sleeve gastrectomy and treating gastroparesis. The Pylorus…
Endoscopic sleeve gastroplasty and bypass are currently available for weight loss in obese patients who have failed nutritional management. Despite very low ris…
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modifica…
Obesity is a chronic disease with a rapidly increasing prevalence, expected to affect up to 25% of the French population by 2030, and is associated with signifi…
Weight loss is of paramount importance to ameliorate obesity-related complications. Endoscopic sleeve gastroplasty is a new therapeutic option to obtain signifi…